These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 28965628

  • 1. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
    Khabaz MN, Abdelrahman AS, Butt NS, Al-Maghrabi B, Al-Maghrabi J.
    Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical expression of galectin-3 is significantly associated with grade, stage and differentiation of endometrial carcinomas.
    Al-Maghrabi J, Abdelrahman AS, Ghabrah T, Butt NS, Al-Maghrabi B, Khabaz MN.
    Pathol Res Pract; 2017 Apr; 213(4):348-352. PubMed ID: 28215640
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance.
    Sivridis E, Giatromanolaki A, Koukourakis MI, Georgiou L, Anastasiadis P.
    Histopathology; 2002 Jan; 40(1):92-100. PubMed ID: 11903603
    [Abstract] [Full Text] [Related]

  • 5. Immunoexpression of Cyclin D1 and PTEN in Various Endometrial Pathologies.
    Shawana S, Kehar SI, Masood S, Aamir I.
    J Coll Physicians Surg Pak; 2016 Apr; 26(4):277-82. PubMed ID: 27097697
    [Abstract] [Full Text] [Related]

  • 6. Clusterin immunoexpression is associated with early stage endometrial carcinomas.
    Al-Maghrabi JA, Butt NS, Anfinan N, Sait K, Sait H, Bajouh O, Khabaz MN.
    Acta Histochem; 2016 May; 118(4):430-4. PubMed ID: 27079858
    [Abstract] [Full Text] [Related]

  • 7. Expression of the cell-cycle regulatory proteins (cyclins D1 and E) in endometrial carcinomas: correlations with hormone receptor status, proliferating indices, tumor suppressor gene products (p53, pRb), and clinicopathological parameters.
    Mitselou A, Ioachim E, Zagorianakou N, Kitsiou E, Vougiouklakis T, Agnantis NJ.
    Eur J Gynaecol Oncol; 2004 May; 25(6):719-24. PubMed ID: 15597850
    [Abstract] [Full Text] [Related]

  • 8. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
    Ozuysal S, Oztürk H, Bilgin T, Filiz G.
    Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
    [Abstract] [Full Text] [Related]

  • 9. PAX2 and cyclin D1 expression in the distinction between cervical microglandular hyperplasia and endometrial microglandular-like carcinoma: a comparison with p16, vimentin, and Ki67.
    Stewart CJ, Crook ML.
    Int J Gynecol Pathol; 2015 Jan; 34(1):90-100. PubMed ID: 25473758
    [Abstract] [Full Text] [Related]

  • 10. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL, Shen DH, Xue WC, Li Y, Yu YZ.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [Abstract] [Full Text] [Related]

  • 11. FGFR2 alterations in endometrial carcinoma.
    Gatius S, Velasco A, Azueta A, Santacana M, Pallares J, Valls J, Dolcet X, Prat J, Matias-Guiu X.
    Mod Pathol; 2011 Nov; 24(11):1500-10. PubMed ID: 21725289
    [Abstract] [Full Text] [Related]

  • 12. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
    Nishimura Y, Watanabe J, Jobo T, Kato N, Fujisawa T, Kamata Y, Kuramoto H.
    Anticancer Res; 2004 Nov; 24(4):2185-91. PubMed ID: 15330159
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic utility of hepatocyte nuclear factor 1-beta immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma.
    Fadare O, Liang SX.
    Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):580-7. PubMed ID: 22495362
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator.
    Shih HC, Shiozawa T, Kato K, Imai T, Miyamoto T, Uchikawa J, Nikaido T, Konishi I.
    Hum Pathol; 2003 May; 34(5):471-8. PubMed ID: 12792921
    [Abstract] [Full Text] [Related]

  • 15. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
    Kimura F, Watanabe J, Hata H, Fujisawa T, Kamata Y, Nishimura Y, Jobo T, Kuramoto H.
    J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
    [Abstract] [Full Text] [Related]

  • 16. The extent of cyclin D1 expression in endometrial pathologies and relevance of cyclin D1 with the clinicopathological features of endometrioid endometrial carcinoma.
    Yildirim HT, Nergiz D, Sadullahoglu C, Akgunduz Z, Yildirim S, Dogan S, Sezer C.
    Indian J Pathol Microbiol; 2020 Mar; 63(3):412-417. PubMed ID: 32769330
    [Abstract] [Full Text] [Related]

  • 17. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas.
    Nikaido T, Li SF, Shiozawa T, Fujii S.
    Cancer; 1996 Sep 15; 78(6):1248-53. PubMed ID: 8826947
    [Abstract] [Full Text] [Related]

  • 18. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis.
    Ruhul Quddus M, Latkovich P, Castellani WJ, James Sung C, Steinhoff MM, Briggs RC, Miranda RN.
    Arch Pathol Lab Med; 2002 Apr 15; 126(4):459-63. PubMed ID: 11900573
    [Abstract] [Full Text] [Related]

  • 19. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
    Němejcová K, Rosmusová J, Bártů M, Důra M, Tichá I, Dundr P.
    Int J Surg Pathol; 2017 Aug 15; 25(5):389-396. PubMed ID: 28381136
    [Abstract] [Full Text] [Related]

  • 20. Nuclear localization of beta-catenin is correlated with the expression of cyclin D1 in endometrial carcinomas.
    Shih HC, Shiozawa T, Miyamoto T, Uchikawa J, Feng Y, Kashima H, Nikaido T, Konishi I.
    Anticancer Res; 2003 Aug 15; 23(5A):3749-54. PubMed ID: 14666673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.